CDK1 and breast cancer: CDC2 (CDK1) CDK1 phosphorylates TFCP2L1, a pluripotency‐associated transcription factor, and the CDK1‐TFCP2L1 pathway is activated in BC cells, stimulating their proliferation, self‐renewal, and invasion.